- Previous Close
3.2000 - Open
3.2500 - Bid 3.3100 x --
- Ask 3.3200 x --
- Day's Range
3.1800 - 3.3500 - 52 Week Range
2.1600 - 3.9706 - Volume
1,188,600 - Avg. Volume
753,820 - Market Cap (intraday)
1.897B - Beta (5Y Monthly) --
- PE Ratio (TTM)
9.71 - EPS (TTM)
0.3400 - Earnings Date Nov 4, 2024
- Forward Dividend & Yield 0.30 (8.96%)
- Ex-Dividend Date Jan 29, 2024
- 1y Target Est
3.85
Empreendimentos Pague Menos S.A. operates a chain of pharmacies in Brazil. The company offers medicines and health care products in the areas of paediatrics, oncology, psychiatry, urology, orthopedics, dermatology, contraception, pediatric endocrinology, assisted reproduction, geriatric, gastrointestinal and hepatic, pain, fever, and inflammation, diabetes, and endocrinology. It also provides personal care and beauty products, including deodorant, intimate care, and oral hygiene, as well as foot, hair, face, and hand care products; dermo-cosmetics; and repellent, diaper, cloth, and food products, as well as other accessories for moms and babies. In addition, the company offers clothing and accessories, supplements, first aid, food and drink, utilities, and others; and cereals, fibers, vitamins and minerals, first aid, and herbal medicines and natural products. Empreendimentos Pague Menos S.A. was incorporated in 1981 and is headquartered in Fortaleza, Brazil.
www.paguemenos.com.br--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PGMN3.SA
View MorePerformance Overview: PGMN3.SA
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PGMN3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PGMN3.SA
View MoreValuation Measures
Market Cap
1.90B
Enterprise Value
5.25B
Trailing P/E
9.71
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
0.71
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
5.58
Financial Highlights
Profitability and Income Statement
Profit Margin
1.32%
Return on Assets (ttm)
3.93%
Return on Equity (ttm)
6.24%
Revenue (ttm)
12.16B
Net Income Avi to Common (ttm)
160.46M
Diluted EPS (ttm)
0.3400
Balance Sheet and Cash Flow
Total Cash (mrq)
169.6M
Total Debt/Equity (mrq)
131.90%
Levered Free Cash Flow (ttm)
234.34M